CELC
Celcuity Inc.
NASDAQ · Healthcare · Biotechnology · US
$68.78
−1.36%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 40.35x
- P/S forward
- 17.05x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -263.30x
- Price / sales
- —
- Price / cash flow
- -17.55x
Enterprise value
- Enterprise value
- $3.4B
- EV / sales
- —
- EV / EBITDA
- -18.17x
- EV / EBIT
- -16.13x
- Market cap
- $3.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026